Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)

SHE:002900 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	680.97	794.07	991.16	1,203	529.83	661.45
Trading Asset Securities	43.06	48.08	57.75	91.25	581.68	360.79
Cash & Short-Term Investments	724.03	842.15	1,049	1,294	1,112	1,022
Cash Growth	-37.41%	-19.71%	-18.93%	16.41%	8.73%	-14.33%
Accounts Receivable	181.89	221.19	99.46	124.6	132.98	157.85
Other Receivables	6.37	13.36	1.73	0.99	0.64	2.85
Receivables	188.26	234.55	101.19	125.59	133.62	160.7
Inventory	321.32	307.67	208.79	161.16	156.55	186.51
Other Current Assets	118.31	87.59	77.54	43.01	25.51	70.71
Total Current Assets	1,352	1,472	1,436	1,624	1,427	1,440
Property, Plant & Equipment	1,433	1,402	1,082	882.45	925.35	867.29
Long-Term Investments	715.84	711.73	708.99	646.87	604.5	14.91
Goodwill	1.34	1.34	1.34	0.5	9.44	9.44
Other Intangible Assets	113.5	112.95	113.37	61.1	62.5	66.42
Long-Term Deferred Tax Assets	30.12	25.22	23.08	24.68	25.84	23.89
Long-Term Deferred Charges	72.48	66.38	57.96	38.4	10.69	56.85
Other Long-Term Assets	9.22	8.88	20.22	-	-	3.8
Total Assets	3,728	3,800	3,443	3,278	3,066	2,483
Accounts Payable	372.49	323.48	182.13	120.84	105.16	90.01
Accrued Expenses	11.17	39.68	78.79	99.3	107.57	129.46
Short-Term Debt	653.31	575.96	275.27	220.22	270.28	269.78
Current Portion of Long-Term Debt	11.06	217.45	201.54	10.17	0.06	-
Current Portion of Leases	-	3.35	3.42	3.4	4.46	-
Current Income Taxes Payable	1.63	0.32	0.04	0.01	0.02	0.27
Current Unearned Revenue	20.51	17.77	43.25	54.79	21.06	19.42
Other Current Liabilities	95.12	79.72	60.61	89	27.99	79.89
Total Current Liabilities	1,165	1,258	845.03	597.73	536.61	588.84
Long-Term Debt	159.97	134.19	229.83	417.78	204.84	-
Long-Term Leases	3.51	4.68	8.33	5.14	8.03	-
Long-Term Unearned Revenue	128.54	103.91	79.03	83.86	88.96	88.71
Long-Term Deferred Tax Liabilities	135.29	135.8	132.54	120.95	110.61	13.63
Total Liabilities	1,593	1,636	1,295	1,225	949.04	691.18
Common Stock	316.36	316.36	316.39	316.6	316.6	316.6
Additional Paid-In Capital	1,091	1,090	1,082	1,043	1,073	1,073
Retained Earnings	737.79	766.64	771.23	729.21	797.94	471.77
Treasury Stock	-13.14	-13.14	-29.54	-47.79	-85.77	-85.77
Total Common Equity	2,132	2,160	2,140	2,041	2,101	1,775
Minority Interest	3.08	4.03	7.73	11.32	15.02	16.3
Shareholders' Equity	2,135	2,164	2,148	2,052	2,116	1,792
Total Liabilities & Equity	3,728	3,800	3,443	3,278	3,066	2,483
Total Debt	827.85	935.63	718.38	656.73	487.67	269.78
Net Cash (Debt)	-103.82	-93.47	330.54	637.17	623.84	752.46
Net Cash Growth	-	-	-48.12%	2.14%	-17.09%	-25.74%
Net Cash Per Share	-0.33	-0.30	1.08	2.11	2.01	2.31
Filing Date Shares Outstanding	320.5	298.74	278.39	309.78	309.78	309.78
Total Common Shares Outstanding	320.5	298.74	278.39	309.78	309.78	309.78
Working Capital	186.63	214.23	591.4	1,026	890.58	851.32
Book Value Per Share	6.65	7.23	7.69	6.59	6.78	5.73
Tangible Book Value	2,017	2,046	2,026	1,979	2,030	1,699
Tangible Book Value Per Share	6.29	6.85	7.28	6.39	6.55	5.49
Buildings	-	913.01	644.88	635.65	640.66	603.42
Machinery	-	1,056	799.09	737.21	716.18	579.06
Construction In Progress	-	162.84	269.26	58.34	45.31	153.26

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.